Key facts
- This page summarizes Michael S. Abrams's Form 3 filing for NRX Pharmaceuticals, Inc. (NRXP).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 Nov 2024, 13:44.
Michael S. Abrams - 18 Nov 2024 Form 3 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- NRXP
- Reported as of
- 18 Nov 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 22 Nov 2024, 13:44:01 UTC
- Prior SEC filing
- 08 Sep 2023
- Next SEC filing
- 11 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael S. Abrams
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael S. Abrams filed Form 3 for NRX Pharmaceuticals, Inc. (NRXP) on 22 Nov 2024.
Change
- Previous filing in this sequence was filed on 08 Sep 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.